Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2017-11-20
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury
NCT04836481
Optimizing Drug Doses in Critically Ill
NCT02437838
Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney Disease
NCT05330390
Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
NCT02726867
Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention
NCT00618436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No study intervention
No study intervention
Levetiracetam
Standard of care
Lacosamide
Standard of care
Phenytoin
Standard of care
Phenobarbital
Standard of care
Ketamine
Standard of care
Valproic Acid
Standard of care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Levetiracetam
Standard of care
Lacosamide
Standard of care
Phenytoin
Standard of care
Phenobarbital
Standard of care
Ketamine
Standard of care
Valproic Acid
Standard of care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Expected to survive for more than 24 hrs
* Achievement of steady state drug concentrations prior to study enrollment
Exclusion Criteria
* Age \< 18
* Prisoner
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maryland, Baltimore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Neeraj Badjatia
Professor of Neurology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neeraj Badjatia, MD
Role: PRINCIPAL_INVESTIGATOR
University of Maryland, College Park
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland Medical Center
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00066222
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.